Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
Clinical trial NCT02168270 · TERMINATED
Trial details
- NCT number
- NCT02168270
- Sponsor
- University of Nebraska
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-16
- Primary completion
- 2015-08-20
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.